7KHV

CpOGA IN COMPLEX WITH LIGAND 54

Summary for 7KHV

Entry DOI	10.2210/pdb7khv/pdb
Descriptor	O-GlcNAcase NagJ, N-(5-{[6-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-2,6-diazaspiro[3.4]octan-2-yl]methyl}-1,3-thiazol-2-yl)acetamide, CALCIUM ION, ... (6 entities in total)
Functional Keywords	glycoside hydrolase, inhibitor, hydrolase, hydrolase-inhibitor complex, hydrolase/inhibitor
Biological source	Clostridium perfringens
Total number of polymer chains	6
Total formula weight	406206.93
Authors	Shaffer, P.L. (deposition date: 2020-10-22, release date: 2020-12-02, Last modification date: 2024-04-03)
Primary citation	Martinez-Viturro, C.M.,Trabanco, A.A.,Royes, J.,Fernandez, E.,Tresadern, G.,Vega, J.A.,Del Cerro, A.,Delgado, F.,Garcia Molina, A.,Tovar, F.,Shaffer, P.,Ebneth, A.,Bretteville, A.,Mertens, L.,Somers, M.,Alonso, J.M.,Bartolome-Nebreda, J.M. Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders. J.Med.Chem., 63:14017-14044, 2020 Cited by PubMed: 33197187 DOI: 10.1021/acs.jmedchem.0c01479 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.3 Å)

Structure validation